logo
Plus   Neg
Share
Email

Bayer Agrees To Voluntary Special Audit Of Due Diligence On Major M&A Deals

Bayer said Thursday that it agreed to allow an independent expert to review its existing specifications and requirements for conducting due diligence on major deal in the future. The company would publish reports of the expert on its website by the end of March.

Bayer reached a agreement with Christian Strenger, a stockholder of the company, on a voluntary special audit of due diligence procedures. The agreement allows Hans-Joachim Böcking of the University of Frankfurt to review the company's existing rules for conducting due diligence for major deal.

Bayer said lawyer Ralph Wollburg of Linklaters and Prof. Dr. Mathias Habersack of the University of Munich would issue more detailed statements about the legal opinions they prepared at the end of 2018 and in early 2019 concerning the duties of the Board of Management in relation to the Monsanto acquisition.

On Wednesday, Bayer said its Chairman Werner Wenning would leave the German drugs and chemicals company before his term expires, amid legal issues surrounding its weedkiller Roundup.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT